Lilly
  • Prescribing Information
  • Patient Prescribing Information
Menu closed
Lilly
  • Prescribing Information
  • Patient Prescribing Information
  • House For Patients
    • ALIMTA® (pemetrexed for injection)
    • CYRAMZA® (ramucirumab)
    • ERBITUX® (cetuximab)
    • Jaypirca™ (pirtobrutinib)
    • Retevmo® (selpercatinib)
    • Verzenio Continuous Care™ Support Program
  • For Healthcare Providers
    • Support and Resources
  • Contact Us
Globe Loading... Reveal available languages
Lilly Oncology Support Center


Welcome to the Lilly Oncology Support Center

Lilly Oncology is committed to helping you receive the care you need

Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones.

We understand that facing the cost of cancer treatment can be difficult. Through the Lilly Oncology Support Center, we strive to offer individualized treatment support for eligible patients prescribed Lilly's product for their cancer treatment. For those who qualify, we can help with:

  • Understanding your insurance coverage
  • Review of financial-assistance options, including savings card programs and independent patient-assistance foundations
  • For some products we provide dedicated, personalized support through every step of treatment.



Woman and child looking out the window

On the following pages, you'll find information on savings card programs and additional resources. These resources may help with financial challenges that some patients experience to get the Lilly medication that they need.

Choose a product:

ALIMTA® (pemetrexed for injection)

CYRAMZA® (ramucirumab)

ERBITUX® (cetuximab)

Jaypirca™ (pirtobrutinib)

Retevmo® (selpercatinib)

Verzenio® (abemaciclib)

Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call 1-866-472-8663
Monday - Friday, 8am — 10pm ET

This site is intended for US residents ages 18 and over.

PP-OC-US-0369 01/2023 ©Lilly USA, LLC 2023. All rights reserved.

ALIMTA®, CYRAMZA®, ERBITUX®, Retevmo®, and Verzenio® are registered trademarks and Jaypirca™ and Verzenio Continuous Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Other product/company names mentioned herein are the property of their respective owners.

Terms of UsePrivacy StatementAccessibility StatementSitemap
Lilly